ExxonMobil
XOM
$160.49
+1.63%
Exxon Mobil Corporation is a global integrated oil and gas giant engaged in the exploration, production, refining, and marketing of petroleum products, as well as the manufacturing of commodity and specialty chemicals. As one of the world's largest publicly traded energy companies, it maintains a dominant market position through its massive scale, vertically integrated operations, and vast reserve base. The current investor narrative is dominated by a bullish environment for oil prices driven by geopolitical supply disruptions, such as a prolonged blockade of Iranian exports and the closure of key shipping lanes, which is expected to generate significant free cash flow windfalls supporting the company's substantial shareholder returns through dividends and buybacks.…
XOM
ExxonMobil
$160.49
Related headlines
Investment Opinion: Should I buy XOM Today?
Rating & Thesis: Hold. ExxonMobil is a high-quality, financially robust integrated energy company offering shareholder returns and defensive characteristics, but its near-term upside appears limited after a significant rally and amid cyclical earnings normalization. The analyst consensus leans cautiously bullish, but the wide EPS estimate range ($10.65-$14.44) reflects high uncertainty.
Supporting Evidence: The stock trades at a reasonable forward PE of 15.14x, below typical integrated peer averages, and an EV/EBITDA of 8.16x. Financial health is exceptional, with a D/E of 0.17 and $23.61B in TTM FCF funding a secure dividend (yield 3.31%, payout 59.74%). However, revenue growth is stagnant (Q4 YoY -1.26%) and margins are compressing (gross margin down ~460 bps from Q1 2024), indicating the earnings cycle has peaked.
Risks & Conditions: The two biggest risks are a sharp downturn in oil prices eroding cash flow and longer-term energy transition pressures. This Hold would upgrade to a Buy if the forward PE compressed below 13x on sustained oil price strength, or if the stock corrected meaningfully toward $130-$140, offering a higher yield and better margin of safety. It would downgrade to Sell if quarterly revenue fell below $75B and FCF dropped precipitously while the valuation remained elevated. The stock is currently fairly valued relative to its mid-cycle fundamentals and peer group.
Sign up to view all
XOM 12-Month Price Forecast
ExxonMobil is a fortress balance sheet company in a favorable but mature phase of the commodity cycle. The 45%+ one-year rally has likely captured much of the near-term upside, leaving balanced risk/reward. The stock is best viewed as a source of income and portfolio stability (low beta) rather than aggressive growth. The stance would turn bullish on a pullback to the $140s, improving the yield and valuation, or bearish if quarterly FCF drops below $4B while oil prices remain elevated, signaling operational issues.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ExxonMobil's 12-month outlook, with a consensus price target around $208.64 and implied upside of +30.0% versus the current price.
Average Target
$208.64
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$128 - $209
Analyst target range
Analyst coverage for ExxonMobil is extensive among institutional firms, with recent ratings from major banks like Morgan Stanley, Barclays, and Wells Fargo maintaining 'Overweight' or 'Buy' stances, while others like HSBC, Mizuho, and Citigroup have 'Hold' or 'Neutral' ratings. This distribution points to a consensus that leans cautiously bullish, acknowledging the strong cash flow and shareholder returns but balancing them against commodity price dependence and longer-term energy transition risks. The average target price and implied upside cannot be calculated from the provided data, which only includes EPS and revenue estimates. The analyst revenue estimate range for the coming period is wide, spanning from $320.58 billion to $405.12 billion, with an average of $358.37 billion. Similarly, the EPS estimate range is $10.65 to $14.44. This wide dispersion in targets signals significant uncertainty and differing views on future commodity price trajectories and the company's operational performance. The high-end estimates likely bake in a scenario of sustained high oil prices and operational excellence, while the low-end estimates may factor in a sharper-than-expected downturn in the energy cycle or margin pressures.
Bulls vs Bears: XOM Investment Factors
The bull case, anchored by exceptional financial strength, robust cash returns, and a reasonable valuation, currently holds stronger evidence. The bear case rightly highlights cyclical earnings pressure and recent momentum deceleration. The single most important tension in the investment debate is the conflict between Exxon's near-term cash flow windfall from a bullish oil price environment and the longer-term secular risks associated with the energy transition. The resolution of this tension—whether the company can successfully navigate the shift while returning capital—will ultimately determine the stock's trajectory beyond the current cycle.
Bullish
- Robust Free Cash Flow & Shareholder Returns: Exxon generated $23.61 billion in TTM free cash flow, funding a 59.74% dividend payout ratio and aggressive buybacks. This substantial cash generation, driven by a favorable oil price environment, provides a tangible return to investors and supports the stock's defensive appeal.
- Strong Financial Health & Low Leverage: The company's fortress balance sheet features a debt-to-equity ratio of just 0.17, indicating minimal financial risk. This low leverage provides resilience during commodity downturns and financial flexibility for strategic investments or further shareholder returns.
- Attractive Valuation Relative to Peers: With a trailing PE of 18.07x and a forward PE of 15.14x, Exxon trades below the typical average for integrated oil majors. Its EV/EBITDA of 8.16x and PS ratio of 1.61x suggest the market is not pricing in an excessive premium for its scale and stability.
- Powerful Long-Term Uptrend: The stock is up 45.44% over the past year and 32.38% over the past six months, demonstrating a sustained bullish trend. Trading at 75% of its 52-week range ($101.19 to $176.41), it shows momentum without being at an extreme peak.
Bearish
- Revenue & Margin Compression: Q4 2025 revenue of $80.04B declined 1.26% YoY, continuing a downtrend from the Q3 2024 peak of $87.79B. Gross margin compressed to 18.89% in Q4 2025 from 23.51% in Q1 2024, reflecting normalization from cyclical highs.
- Cyclical Dependence & Earnings Volatility: Profitability is directly tied to volatile oil prices, as evidenced by the wide analyst EPS estimate range of $10.65 to $14.44. The current net margin of 8.12% and ROE of 11.12% are below peak-cycle levels, highlighting earnings sensitivity.
- Short-Term Momentum Deceleration: Recent performance has lagged the market, with a 3-month relative strength of -2.04% versus the S&P 500. The 1-month gain of 5.98% and 3-month gain of 6.38% have decelerated significantly from the explosive 32.38% six-month gain, suggesting consolidation.
- Long-Term Energy Transition Risk: As a fossil fuel giant, Exxon faces secular headwinds from the global shift to renewable energy. While not an immediate earnings threat, this overhang can compress long-term valuation multiples and create regulatory uncertainty.
XOM Technical Analysis
The stock is in a sustained, powerful uptrend, evidenced by a 45.44% gain over the past year. The current price of $157.92 sits at approximately 75% of its 52-week range ($101.19 to $176.41), indicating it is trading closer to recent highs but not at an extreme peak, suggesting room for continued momentum if bullish fundamentals persist. Recent momentum shows a mixed picture: the stock is up 5.98% over the past month and 6.38% over the past three months, but this short-term performance has decelerated from the explosive 32.38% six-month gain and notably underperformed the S&P 500 over the last three months, as indicated by a relative strength of -2.04%. This divergence suggests the stock may be consolidating after its major run-up, potentially digesting gains before its next directional move. Key technical support is anchored at the 52-week low of $101.19, while immediate resistance is at the 52-week high of $176.41. A decisive breakout above $176.41 would signal a resumption of the primary uptrend and likely target new all-time highs, whereas a breakdown below the recent consolidation range near $144-$150 could indicate a deeper correction. The stock exhibits low market-relative volatility with a beta of 0.183, meaning it has been approximately 82% less volatile than the broader market (SPY) over the measured period, which is atypical for an energy stock and suggests it has traded with defensive characteristics, potentially due to its integrated business model and stable dividend.
Beta
0.18
0.18x market volatility
Max Drawdown
-15.7%
Largest decline past year
52-Week Range
$101-$176
Price range past year
Annual Return
+48.3%
Cumulative gain past year
| Period | XOM Return | S&P 500 |
|---|---|---|
| 1m | +9.6% | +4.0% |
| 3m | +9.8% | +8.2% |
| 6m | +36.8% | +11.5% |
| 1y | +48.3% | +24.3% |
| ytd | +30.9% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
XOM Fundamental Analysis
Revenue has shown stability with a slight recent dip; Q4 2025 revenue was $80.04 billion, representing a modest year-over-year decline of 1.26%. However, examining the quarterly trend reveals revenue peaked in Q3 2024 at $87.79 billion and has since trended lower through 2025, with Q1-Q4 2025 figures of $81.06B, $79.48B, $83.33B, and $80.04B, indicating a period of consolidation from the prior cycle's highs. The Energy Products segment, contributing $131.9 billion, remains the dominant growth and earnings driver, heavily influenced by refining margins and oil prices. The company remains solidly profitable, with Q4 2025 net income of $6.50 billion and a net margin of 8.12%. Profitability has compressed from higher levels seen in 2024; for instance, gross margin in Q4 2025 was 18.89%, down from 23.51% in Q1 2024. This margin compression reflects the normalization of energy prices and refining cracks from their post-crisis peaks, though absolute earnings remain robust by historical standards. Financial health is exceptionally strong, characterized by a fortress balance sheet. The debt-to-equity ratio is a conservative 0.17, indicating minimal financial leverage. The company generated substantial free cash flow of $23.61 billion over the trailing twelve months, providing ample internal funding for its capital program, dividends (payout ratio of 59.74%), and aggressive share repurchases. Return on Equity (ROE) stands at 11.12%, which, while healthy, is below the levels achieved during the peak of the commodity cycle, reflecting the current phase of the earnings cycle.
Quarterly Revenue
$80.0B
2025-12
Revenue YoY Growth
-0.01%
YoY Comparison
Gross Margin
+0.18%
Latest Quarter
Free Cash Flow
$23.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is XOM Overvalued?
Given the company's substantial profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 18.07x, while the forward PE is 15.14x. The forward multiple being lower than the trailing multiple implies analysts expect earnings growth, with the market pricing in an improvement in net income. Compared to industry averages, ExxonMobil's valuation appears mixed. Its trailing PE of 18.07x is below the typical integrated oil major average (often in the low 20s), suggesting a relative discount. Its Price-to-Sales (PS) ratio of 1.61x and EV-to-EBITDA of 8.16x also appear reasonable for a company of its scale and financial strength, indicating the market is not assigning an excessive premium for its integrated model. Historically, the stock's current trailing PE of 18.07x sits below its own multi-year range observed in the historical data, which has seen peaks above 20x during periods of lower earnings and troughs near 8x during the peak earnings of 2022. This positioning suggests the stock is not at historical valuation extremes; it is priced for a mid-cycle environment rather than peak cycle euphoria or deep cyclical despair, offering a balanced risk-reward profile from a historical context.
PE
18.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Exxon's primary financial risk is earnings volatility tied directly to the commodity cycle, as seen in the sequential decline from a Q3 2024 revenue peak of $87.79B to Q4 2025's $80.04B. While the balance sheet is strong (D/E 0.17), profitability metrics like net margin (8.12%) and ROE (11.12%) have compressed from prior highs, indicating the company is not immune to margin pressure as energy prices normalize. Revenue concentration in the Energy Products segment ($131.9B) creates dependence on refining margins and oil prices, though its integrated model provides some diversification.
Market & Competitive Risks: The stock trades at a forward PE of 15.14x, which is reasonable but not deeply discounted, leaving it exposed to valuation compression if the oil price cycle turns. Its low beta of 0.183 suggests it has traded defensively, but this could reverse if it is re-rated as a pure cyclical play. Competitive and regulatory risks are heightened by the long-term energy transition, which could pressure long-dated asset valuations. Recent news highlights geopolitical supply disruptions (Iran blockade, Strait of Hormuz) as both a near-term catalyst and a source of long-term market volatility.
Worst-Case Scenario: A severe global recession coupled with a breakdown of OPEC+ supply discipline could lead to a rapid collapse in oil prices, compressing Exxon's margins back to trough levels. This could trigger analyst downgrades to the low end of the EPS range ($10.65), multiple compression toward historical lows, and a test of the stock's 52-week low of $101.19. From the current price of $157.92, this adverse scenario implies a potential downside of approximately -36%.
FAQ
The key risks are, in order of severity: 1) Commodity Price Risk: Earnings are directly tied to volatile oil prices (EPS estimate range: $10.65-$14.44). 2) Cyclical Downturn Risk: Revenue has declined sequentially from a 2024 peak, and margins are compressing. 3) Long-Term Secular Risk: The global energy transition poses a threat to long-dated fossil fuel assets and future valuation multiples. 4) Execution & Geopolitical Risk: Operational missteps or a sudden resolution of supply disruptions could negatively impact cash flow.
Our 12-month forecast outlines three scenarios: a Bull Case (30% probability, target $176-$190) on sustained high oil prices, a Base Case (55% probability, target $155-$175) on stable mid-cycle conditions, and a Bear Case (15% probability, target $101-$140) on an oil price collapse. The Base Case is most likely, assuming Exxon meets average analyst EPS estimates of ~$12.34 and maintains its shareholder return program, leading to range-bound trading with a slight upward bias.
XOM appears fairly valued relative to its current mid-cycle fundamentals. Its forward PE of 15.14x is below the typical average for integrated oil majors, suggesting no excessive premium. Compared to its own history, a trailing PE of 18.07x sits below prior peaks above 20x, indicating it is not at a cyclical valuation extreme. The market is pricing in stable, but not booming, earnings with a focus on capital returns rather than explosive growth.
XOM is a good buy for income-focused, risk-averse investors seeking stability and a 3.31% dividend yield supported by $23.61B in annual free cash flow. However, after a 45% one-year rally, near-term capital appreciation potential appears limited, with the stock fairly valued at a forward PE of 15.14x. For growth-oriented investors, the stagnant revenue trend and cyclical dependence reduce its appeal. It becomes a more compelling buy on a pullback toward the $140-$150 range.
XOM is primarily suitable for long-term investment (3-5 year minimum horizon) due to its cyclical nature and income-oriented profile. Its low beta (0.183) and reliable dividend make it a stabilizing holding for long-term portfolios. Short-term trading is challenged by the stock's recent consolidation and decelerating momentum relative to the market. The dividend also incentivizes holding through cycles to capture the yield.
